Extracorporeal cardiopulmonary support (ECS) of donors after cardiac death (DCD) has been shown to improve abdominal organs for transplantation. This study assesses whether pulmonary congestion occurs during ECS with the heart arrested and describes an in vivo method to assess if lungs are suitable for transplantation from DCD donors after ECS resuscitation. Cardiac arrest was induced in 30 kg pigs, followed by 10 min of warm ischemia. Cannulae were placed into the right atrium (RA) and iliac artery, and veno-arterial ECS was initiated for 90 min with lungs inflated, group 1 (n ‫؍‬ 5) or deflated, group 2 (n ‫؍‬ 3). Left atrial pressures were measured as a marker for pulmonary congestion. After 90 min of ECS, lung function was evaluated. Cannulae were placed into the pulmonary artery (PA) and left ventricle (LV). A second pump was included, and ECS was converted to a bi-ventricular (bi-VAD) system. The RVAD drained from the RA and pumped into the PA, and the LVAD drained the LV and pumped into the iliac. This brought the lungs back into circulation for a 1-hr assessment period. The oxygenator was turned off, and ventilation was restarted. Flows, blood gases, PA and left atrial pressures, and compliance were recorded. In both the groups, LA pressure was <15 mm Hg during ECS. During the lung assessment period, PA flows were 1.4 -2.2 L/min. PO 2 was >300 mm Hg, with normal PCO 2 . Extracorporeal cardiopulmonary support resuscitation of DCD donors is feasible and allows for assessment of function before procurement. Extracorporeal cardiopulmonary support does not cause pulmonary congestion, and the lungs retain adequate function for transplantation. Compliance correlated with lung function.
Lung transplantation is a successful treatment for patients with end-stage pulmonary disease; however, there is a critical shortage of available organs for transplantation. Currently, in the United States there are 2,324 patients in the waiting list with 1,405 transplants in 2006. 1 The vast majority of lung transplantations are from brain dead donors with functional circulation. The use of lungs from donors after cardiac death (DCD)-also known as non-heart beating donors (NHBD)-could increase the number of available organs.
The use of extracorporeal cardiopulmonary support (ECS) on the donor after cardiac death has been shown experimentally and clinically to increase the number and the quality of abdominal organs at our institution. [2] [3] [4] Extracorporeal cardiopulmonary support resuscitation of DCD organs is alsobeing used, currently, in a few centers around the world to resuscitate kidneys and livers with excellent results. [5] [6] [7] [8] [9] [10] Lungs from DCD donors may also be appropriate for transplantation. However, there is no current technique to evaluate their function before procurement. The first lung transplant was performed in 1963 by Hardy et al., 11 and it was from a non-heart beating donor. Since then, successful clinical application of lung transplantation from DCD donors has been reported only in small patient groups. [12] [13] [14] A group in Madrid, Spain, recently published promising results of 17 lung transplants from the DCD resuscitated on ECS. 12 However, they did report higher rates of primary graft dysfunction. Aside from this report, DCD lungs resuscitated with ECS have not been considered for procurement because of concerns with pulmonary congestion that may occur with the arrested heart. This is similar to what can happen during the application of venoarterial extracorporeal membrane oxygenation (ECMO) in a patient with severe cardiomyopathy. 15 Furthermore, there has been no previously described method to assess lung function from a DCD donor before procurement.
The experiments described here used a swine model of DCD to investigate whether pulmonary congestion occurs during ECS resuscitation. In addition, lung function was assessed in situ in the donor to determine quality before procurement.
Materials and Methods

Animals and Anesthesia
Eight swine weighing 27.6 kg Ϯ 1.2 kg were used. Animals were treated according to guidelines in Guide for the Care and Use of Laboratory Animals (U.S. National Institutes of Health, Publication No. 85-23, National Academy Press, Washington, DC, revised 1996), and all methods were approved by the University of Michigan Committee for the Use and Care of Animals.
Anesthesia was induced with 3 mg/kg of telezol (Tiletamine HCL and Zolazepam HCL; Fort Dodge Animal Health, Fort Dodge, IA) and 6 mg/kg of xylazine (VEDCO, St Joseph, MO). Anesthesia was maintained with inhaled isoflurane (Hospira, Inc., Lake Forest, IL). Arterial and central venous pressures were monitored via the carotid and jugular.
Surgical Instrumentation
A median sternotomy was performed, and a flow probe (Transonic Systems Inc., Ithaca, NY) was placed around the pulmonary artery (PA). Catheters were placed into the PA and the left atrium (LA) for blood samples and pressure measurement. Baseline arterial PO 2 and PCO 2 were measured using an ABL 5 blood gas analyzer (Radiometer, Copenhagen, Denmark) and PA pressure and flow and LA pressure were recorded for calculating pulmonary vascular resistance (PVR).
Baseline lung compliance was obtained by slowly inflating the lungs with a ventilator (Nellcor Puritan Bennett 840 Series Ventilator, Tyco Health, Carlsbad, CA). This measure served as a means to assess donor lung quality before transplantation. A peak pressure of 30 cm H 2 O was set at a respiratory rate of 4 breaths/min, resulting in inspiratory plateau pressures of 30 cm H 2 O for 10 seconds. The tidal volume was measured, and compliance was calculated as tidal volume divided by 30 cm H 2 O. A 14 French cannula (Biomedicus, Medtronics, Minneapolis, MN) was placed in the distal retroperitoneal iliac artery as our ECS reinfusion line. A 24 French cannula (DLP, Medtronics) was placed into the right atrium (RA) to mimic a clinical jugular venous drainage line.
Cardiac arrest was induced by infusing pancuronium (Hospira, Inc., Lake Forest, IL) and by removing ventilator support. The pig was anticoagulated with 150 U/kg of heparin before removal of the ventilator. After cardiac arrest, we allowed 10 minutes of warm ischemia before commencing ECS. Cardiac arrest typically took 8 -17 minutes and was indicated by clinical asystole, the absence of a pulse when the arterial tracing was Ͻ20 mm Hg and the difference between systole and diastole was Ͻ10 mm Hg. Figure 1 gives the timeline for the experiment.
ECS Resuscitation
The ECS circuit (Figure 2A ) consisted of 1 ⁄4 inch R3603 TYGON tubing (Fisher Scientific, Pittsburgh, PA), 3/16 inch Nalgene 50 Silicone tubing (Nalge Company, Rochester, NY), a Cobe roller pump (Lakewood, CO), and a Capiox SX25 oxygenator (Terumo, Elkton, MD). The circuit was primed with 500 ml of lactated Ringer's solution with 50 mEq of bicarbonate. Extracorporeal cardiopulmonary support flows were measured by a T208 Transonic tubing flow meter (T208; Transonic Systems, Ithaca, NY).
After warm ischemia, ECS was started. Extracorporeal cardiopulmonary support flows were maintained between 40 ml ⅐ kg Ϫ1 ⅐ min Ϫ1 and 80 ml ⅐ kg Ϫ1 ⅐ min Ϫ1 , aiming to maximize flows without causing cavitation. The heart was maintained in the arrested state by administration of 1.5 g of lidocaine and by ligation of the coronary arteries. During this period, LA pressures were recorded every 15 minutes after initiating ECS as a surrogate marker for pulmonary congestion. During ECS resuscitation, pigs were divided into two groups. In group 1 (static hold, n ϭ 5), the lungs were kept inflated at 20 cm H 2 O with air to prevent atelectasis. In group 2 (deflated, n ϭ 3), the lungs remained deflated.
Lung Function Assessment
After 90 minutes of ECS, the pigs were converted to biventricular (bi-VAD) assist support to bring the lungs back into circulation and assess their function (Figure 2B) . A 22 French canula (DLP, Medtronics) was placed into the PA. A 28 French cannula (DLP, Medtronics) was placed into the left ventricle (LV). The ECS roller pump was switched to drain from the RA and infuse into the PA, thus acting as an RVAD. A second pump with a built in reservoir (M-Pump, MC3, Ann Arbor, MI) drained from the LV and infused into the iliac artery, thus acting as an LVAD. Pulmonary artery flows controlled by the RVAD were maintained low in the beginning of this period and increased up to the point where cavitation started to occur in the system, and this was the maximum flow. LVAD flow rates where equivalent to RVAD flow rates. With the lungs back into circulation, the oxygenator was turned off. Ventilation recommenced with pure oxygen, a respiratory rate of 6 -12, peak inspiratory pressures of 20 -30 cm H 2 O, and a positive endexpiratory pressure (PEEP) of 5 cm H 2 O. At 10, 20, 30, 45, and 60 minutes, blood samples were obtained from the PA and LA to determine PO 2 and PCO 2 to assess ventilation and oxygenation. Pulmonary artery flow was measured and PA and LA pressures were obtained every 10 minutes. Lung compliance was again performed using the previous methods. The experiment concluded after 60 minutes of ventilation.
Wet-Dry Ratio and Histology
The lingula of each lung was removed, weighed, and dried in an oven (Stabletemp, OakLon, VA) at 38 -40°C for 1 week. It was then reweighed, and the wet-dry ratio was calculated. Similar samples were acquired from normal swine that did not undergo this procedure and wet-dry ratios were determined. Wedge biopsies of the lung were procured and fixed in 10% formalin. They were processed in standard fashion and stained with hematoxylin and eosin.
Statistical Analysis
A mixed model analysis was used with SPSS (Chicago, IL) for analyzing between study times and groups. The subject vari-able was swine number, and the fixed independent factors were time, group, and the interaction variable time. Post hoc multiple comparison between times was performed using Bonferroni corrected confidence intervals for all variables. Wet-dry ratio was compared using analysis of variance, with Tukey's multiple comparison method. All figures are presented using standard error of the mean.
Results
Extracorporeal Support (ECS)
In both the groups, ECS was successful. Figure 3 shows mean arterial pressure (MAP) and ECS flows in both the groups for 90 minutes. Flows for group 1 (static hold) ranged from 1.08 Ϯ 0.07 to 1.41 Ϯ 0.07 L/min (44.3-57.6 ml ⅐ kg Ϫ1 ⅐ min Ϫ1 ). Flows for group 2 (deflated) ranged from 0.99 Ϯ 0.24 to 1.78 Ϯ 0.11 L/min (41.2-74.2 ml ⅐ kg Ϫ1 ⅐ min Ϫ1 ). Mean arterial pressure during ECS for group 1 was between 27.4 Ϯ 2.7 and 58.0 Ϯ 10.2 mm Hg. Mean arterial pressure for group 2 was between 27.0 Ϯ 10.21 and 59.7 Ϯ 5.8 mm Hg. Group 2 had statistically higher flows than group 1 (p Ͻ 0.05), but MAP were similar (p ϭ 0.52). Left atrial (LA) pressure in group 1 was 7.2 Ϯ 0.6 mm Hg when ECS increased significantly to 14.6 Ϯ 1.0 mm Hg at the end of 90 minutes (p Ͻ 0.05). Left atrial pressure in group 2 was 3.0 Ϯ 2.0 mm Hg at the beginning of ECS, and it increased significantly to 9.0 Ϯ 2.0 mm Hg (Figure 4) . Left atrial pressure was consistently higher in group 1 compared with that in group 2 (p Ͻ 0.003). The hematocrit for all animals during this stage was 24.8%-26.9% with no significant difference between the groups.
Bi-VAD Lung Assessment
Pulmonary artery flows in group 1 (static hold) were 1.96 Ϯ 0.24 L/min at baseline and ranged from 1.41 Ϯ 0.11 to 1.61 Ϯ 0.08 L/min during the assessment period ( Figure  5) . In group 2 (deflated), PA flow was 2.15 Ϯ 0.08 L/min at baseline and ranged from 1.53 Ϯ 0.13 to 1.69 Ϯ 0.18 L/min during the assessment period. In both the groups, PA flows were significantly decreased compared with baseline (p Ͻ 0.05), but there was no statistical difference between the two groups.
Pulmonary vascular resistance in group 1 was 6.52 Ϯ 2.93 mm Hg ⅐ L Ϫ1 ⅐ min Ϫ1 at baseline and ranged from 11.72 Ϯ 3.05 to 14.38 Ϯ 3.23 mm Hg ⅐ L Ϫ1 ⅐ min Ϫ1 during the assess-ment period (Figure 6) . In group 2, PVR was 4.81 Ϯ 0.66 mm Hg ⅐ L Ϫ1 ⅐ min Ϫ1 at baseline and ranged from 7.48 Ϯ 0.89 to 12.19 Ϯ 5.70 mm Hg ⅐ L Ϫ1 ⅐ min Ϫ1 during the assessment period. In both groups, PVR was significantly increased compared to baseline (p Ͻ 0.003), but there was no statistical difference between the two groups.
Average arterial PO 2 s were Ͼ300 mm Hg at all time points for both the groups with no significant difference between the two groups (p ϭ 0.5; Figure 7) . In group 1, mixed venous PO 2 ranged from 30.9 Ϯ 1.4 to 40.3 Ϯ 4.3 mm Hg. In group 2, mixed venous PO 2 ranged from 29.1 Ϯ 1.3 to 41.4 Ϯ 12.0 mm Hg. There was no statistical difference between the two groups (Figure 7) . Average PCO 2 during this period remained within the normal range at all time points for both the groups with no statistical difference between the two groups (Figure 8) . The hematocrit for all animals during this part ranged from 24.4% to 21.5% with no significant difference between the two groups.
Compliance
Compliance remained near baseline in most sheep (Figure 9 ). Only two (1b and 2b) showed a marked decrease of compliance to below 20 ml/cm H 2 O. Characteristics of these two animals were compared with those with compliance above 20 ml/cm H 2 O during the assessment period. Compliant lungs (Ͼ20 ml/cm H 2 O) had much better lung function parameters including PVR, PO 2 , and PCO 2 compared with the poorer compliant lungs (Ͻ20 ml/cm H 2 O; Table 1 ).
Lung Tissue
The wet-dry ratio was 4.94 Ϯ 0.16 for the normal control samples, 5.59 Ϯ 0.19 for group 1, and 5.65 Ϯ 0.09 for group 2. There was no statistical difference between the two groups but both were statistically larger than normal lungs. Lung histology of all animals was normal.
Discussion
In the past decade, a few institutions have used veno-arterial extracorporeal circulation to restart perfusion of abdominal organs from DCD or NHBD. [3] [4] [5] [6] [7] [8] 16 Extracorporeal cardiopulmonary support is applied while the organs are still within the body for periods ranging from 30 minutes to 4 hours before procurement. Extracorporeal cardiopulmonary support has been used to cool the abdominal organs in an effort to limit ischemic injury. 6, 16 Extracorporeal cardiopulmonary support at normal body temperature has also been instituted and shown experimentally to improve abdominal organ function compared with organs from donors not resuscitated with ECS. 2, [17] [18] [19] The mechanism for this has not been fully understood. However, normothermic ECS has been experimentally shown to increase the energy profile 17 and antioxidants level in the harvested organs. 18 Finally, normothermic ECS may allow ischemic preconditioning and subsequently cause the organ to be more resistant to reperfusion injury on implantation. 19 In the studies described earlier, the aorta was occluded during ECS with a balloon to improve circulation to the abdominal organs. This effectively prevented blood flow to the thoracic organs and prevents resuscitation of the heart. In this study, resuscitation of the heart was eliminated, but the lungs should have received flow from the bronchial artery. Bronchial artery flow during cardiopulmonary bypass has been shown to participate in respiratory exchange, and it is able to support metabolism in the lung parenchyma. 20 Several studies have suggested that bronchial flow during cardiopulmonary bypass plays a role in preventing lung dysfunction after bypass 21, 22 by mediating reperfusion injury and by decreasing lung edema. 23 These studies suggest that allowing bronchial flow to occur during ECS resuscitation may improve the quality of the donor lungs.
Left-sided distension of the heart during ECS of patients with profound cardiac dysfunction is common. 24 Similarly, there are concerns that left atrial distension could cause pulmonary congestion during ECS resuscitation in a DCD donor when the heart is arrested. Left atrial distension can occur from aortic regurgitation through an incompetent aortic valve in a dilated and arrested heart. It can also occur from blood return through the thesbian veins and from bronchial artery flow. In clinical ECMO, left-sided decompression is accomplished using direct venting, balloon atrial septostomy, or placement of a transseptal atrial cannula. 24 -28 It can also be managed by increasing the ECMO pump flow, thereby draining the right heart more effectively and decreasing pulmonary blood flow. 29 In a nonbeating, dilated heart with incompetent mitral and pulmonic valve, retrograde flow through the PA may occur, effectively decompressing the pulmonary vasculature and left heart and preventing pulmonary congestion. Although it was not specifically evaluated, there were small amounts of retrograde flow (50 -150 ml/min) through the PA during the ECS period. This may explain why left atrial pressures remained low in our model during 90 minutes of ECS resuscitation. Lungs from DCD donors have been described to be more tolerable of warm ischemia than abdominal organs. 30 Lung parenchymal cells are close to sources of oxygen in the alveolar spaces, and respiration can occur through passive diffusion. 31 Indeed, experiments have shown inflation or ventilation with oxygen or air can sustain and improve lungs from DCD donors. [31] [32] [33] In this limited study, static inflation of room air during ECS resuscitation did not seem to be necessary for maintaining lung function.
A significant obstacle to using lungs from DCD donors is the inability to assess function before transplantation. The ability to adequately assess function is vital before transplanting a life-sustaining organ such as the lung. Steen et al. 34 have developed a very elegant method to assess lung function before transplantation. After procurement from a DCD donor and cold storage, the heart lung block is placed into a modified heart-lung machine to be assessed ex vivo before implantation. Reperfusion is accomplished via the PA using a perfusate with deoxygenated blood while ventilating the lungs. Thus, gas exchange and pulmonary hemodynamics can be evaluated before transplantation. Steen's group went on further to show that nonacceptable donor lungs could be successfully recon- ditioned to a better state and subsequently transplanted with good function. 35, 36 In this study, a simple method was used to assess lung function before procurement in a DCD donor that is already on ECS resuscitation for the abdominal organs. By transitioning from veno-arterial ECS to a RVAD/LVAD circulation system, one can bring the lungs back into circulation. With the lungs back in circulation and the oxygenator turned off, the DCD donor's body acts as the deoxygenator. With the ventilator turned on, deoxygenated blood will be pumped through the lungs for assessment. Moreover, dynamic compliance could be used to simplify assessment of lung quality. A less compliant lung (Ͻ20 ml/cm H 2 O) likely predicts poor function, and a more compliant lung (Ͼ20 ml/cm H 2 O) may predict good function.
Conclusions
This study suggests that lungs do not become significantly congested over 90 minutes during ECS when the heart is arrested even without an aortic occlusive balloon. This study also indicates that lung function is suitable for transplantation after ECS with or without inflation. Finally, this study indicates that compliance of the donor lung may be an effective tool to determine viability after ECS. This work is further evidence of the promise of extracorporeal support expanding the donor organ pool.
